TNXP ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง8/10/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-2.44
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)13.54M
Tonix Pharmaceuticals Holding Corp ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Tonix Pharmaceuticals Holding Corp ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Tonix Pharmaceuticals Holding Corp ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Tonix Pharmaceuticals Holding Corp ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Tonix Pharmaceuticals Holding Corp ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
TNXP ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง11/9/2026(Pre-Market)
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)-2.45
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)16.72M
TNXP FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)-14.5799.92%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)13.11M29.85%
Tonix Pharmaceuticals Holding Corp(TNXP) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 8/10/2026 | 06/2026 | -2.44/-2.70 | 13.54M/7.72M | 9.60% | 75.38% |
| 5/11/2026 | 03/2026 | -2.93/-2.43 | 6.88M/6.13M | -20.51% | 12.29% |
| 3/14/2026 | 12/2025 | -3.96/-3.19 | 5.39M/2.88M | -24.25% | 86.94% |
| 11/10/2025 | 09/2025 | -3.59/-3.58 | 3.29M/3.10M | -0.07% | 6.13% |
| 8/11/2025 | 06/2025 | -3.86/-3.21 | 2.00M/2.43M | -20.01% | -17.89% |
| 5/12/2025 | 03/2025 | -2.84/-3.23 | 2.43M/2.55M | 12.10% | -4.75% |
| 3/18/2025 | 12/2024 | -9.82/-387.12 | 2.58M/3.50M | 97.46% | -26.23% |
| 11/12/2024 | 09/2024 | -22.88/-293.33 | 2.82M/3.08M | 92.20% | -8.48% |